Perioperative Infection Rate in Patients with Osteosarcomas Treated with Resection and Prosthetic Reconstruction
Authors:
- Vincent M. MorettiVMVincent M. Moretti
- Adedayo O. AshanaAAAdedayo O. Ashana
- Richard D. LackmanRLRichard D. Lackman
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 469 (10) , 2889-2894
Abstract
Tive infection is unclear. Questions/purposes We determined the incidence of perioperative infection in patients with osteosarcoma treated with segmental prosthetic replacement using a standard perioperative antibiotic regimen and the incidence of late infections and wound complications. Patients and Methods We retrospectively reviewed the records of 53 patients with osteosarcoma undergoing segmental prosthetic replacements from 1993 to 2008. There were 30 males and 23 females ranging from 10 to 78 years of age. All patients were given intraoperative antibiotics (intravenous cefazolin), continued for 3 days postoperatively and then given orally for 5 days. Patients who were allergic to penicillin or cefazolin were given vancomycin followed by clindamycin. A perioperative infection was defined as a deep infection within 2 months after prosthetic reconstruction. The minimum followup was 1 year (range, 1-15 years). Results We identified one confirmed perioperative prosthetic infection (1/53; 1.9%) (Enterobacter cloacae and methicillin-resistant Staphylococcus) in a 78-year-old woman after proximal tibial replacement, gastrocnemius flap, and skin graft. Her infection was controlled with débridement, drainage, and intravenous antibiotics. Three patients had late infections, two of which were culture negative. Four patients had wound complications that required further surgery. Conclusion The antibiotic regimen we used is longer than that recommended for patients having routine total joint arthroplasty. Its appropriateness will require comparison with alternate regimens, including those of shorter duration. Level of Evidence Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence....Keywords
This publication has 30 references indexed in Scilit:
- Medium to long‐term results after reconstruction of bone defects at the knee with tumor endoprosthesesJournal of Surgical Oncology, 2010
- Survivorship Analysis of 141 Modular Metallic Endoprostheses at Early FollowupClinical Orthopaedics and Related Research, 2004
- Infection after total hip arthroplastyThe Journal of Bone and Joint Surgery. British volume, 2003
- Limb Salvage With Tumor Endoprostheses for Malignant Tumors of the KneeClinical Orthopaedics and Related Research, 2002
- Contribution of hospital characteristics to the volume–outcome relationship: Dislocation and infection following total hip replacement surgeryArthritis & Rheumatism, 2002
- Distal Femur Resection With Endoprosthetic ReconstructionClinical Orthopaedics and Related Research, 2002
- Modular megaprosthesis for distal femoral tumorsInternational Orthopaedics, 2001
- Reconstruction of Hip Stability After Proximal and Total Femur ResectionsClinical Orthopaedics and Related Research, 2000
- Endoprosthetic Replacement for Stage IIB OsteosarcomaClinical Orthopaedics and Related Research, 1991
- PROPHYLACTIC CEFAZOLIN VERSUS PLACEBO IN TOTAL HIP REPLACEMENT Report of a Multicentre Double-blind Randomised TrialThe Lancet, 1981